US.RVTY · Revvity

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.3,
      "details": {
        "atrPct": 3.441245520820462,
        "turnoverUsdM": 251.14602250000004,
        "liquidityPoints": 0.6,
        "volatilityPoints": 0.7
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.RVTY",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 150.72,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 1,
        "rsi_score": 3,
        "macd_score": 1.5,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1,
      "stop_loss_percent": 6.9,
      "take_profit_price": 173.3249,
      "target_multiplier": 1.9,
      "technical_strength": 1.63,
      "take_profit_percent": 7.1
    },
    "positionPoints": 1.3,
    "stopLossPoints": 1.8,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 6.882491041640924,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 68.5,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 60.5,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 8
  },
  "market": {
    "ma20": 154.809,
    "ma50": 141.8674,
    "close": 161.86,
    "prevClose": 160.39,
    "avgVolume20": 1787116,
    "volumeRatio": 0.87,
    "changePercent": 0.92
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 8,
    "details": {
      "ret_5d": 0.03749763288402663,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 8,
      "vcp_bonus": 0,
      "vol_ratio": 0.8670524268806509,
      "ret_points": 8,
      "vol_points": 0,
      "range_ratio": 1.041506563067273,
      "volat_points": 0,
      "day_range_pct": 0.040034536018781576,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 0,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 68.5,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 2.3,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 46,
        "contribution": 2.3
      },
      {
        "raw": 12.4,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 62,
        "contribution": 12.4
      },
      {
        "raw": 6.4,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 42.67,
        "contribution": 6.4
      },
      {
        "raw": 6,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 30,
        "contribution": 6
      },
      {
        "raw": 6.5,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 65,
        "contribution": 6.5
      },
      {
        "raw": 20.9,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 69.67,
        "contribution": 20.9
      },
      {
        "raw": 6,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 60,
        "contribution": 6
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "觀望",
    "result": 60.5,
    "details": [
      "基本面分析總分: 2.3/5分",
      "資金流分析總分: 12.4/20分",
      "市場環境分析總分: 6.4/15分",
      "催化劑分析: 6/20分",
      "風險管理總分: 6.5/10分",
      "技術信號分析總分: 20.9/30分",
      "情緒分析: 6/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 6,
      "基本面": 2.3,
      "資金流": 12.4,
      "市場環境": 6.4,
      "情緒分析": 6,
      "技術信號": 20.9,
      "風險管理": 6.5
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 6,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 7,
              "catalystCount": 1
            }
          },
          "catalystPoints": 6
        }
      },
      "基本面": {
        "max": 5,
        "grade": "較差",
        "items": {
          "pbPoints": 0.4,
          "pePoints": 0.2,
          "epsPoints": 0,
          "roePoints": 0,
          "debtPoints": 0.5,
          "marginPoints": 0,
          "turnoverUsdM": 251.14602250000004,
          "volumePoints": 0.5,
          "revenuePoints": 0,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.4
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "一般",
        "items": {
          "cmfPoints": 0.8,
          "mfiPoints": 1.6,
          "obvPoints": 4,
          "vwapPoints": 4,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.RVTY",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "較差",
        "items": {
          "vix": {
            "score": 1.8,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 18.39
            }
          },
          "trend": {
            "score": 1.7999999999999998,
            "details": {
              "qqq": {
                "ma20": 733.18400235,
                "ma50": 725.2621992000002,
                "name": "QQQ",
                "close": 721.23999,
                "points": 0.4
              },
              "spy": {
                "ma20": 770.4114959000001,
                "ma50": 767.5287948999999,
                "name": "SPY",
                "close": 769.65997,
                "points": 1.4
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 3.441245520820462,
          "atrPoints": 2,
          "cciPoints": 0.8,
          "vixPoints": 1.8,
          "marketTrendPoints": 1.7999999999999998
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "一般",
        "items": {
          "sentiment": {
            "score": 6,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 7,
              "negativeHits": 0,
              "positiveHits": 4,
              "sentimentScoreRaw": 1.4
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 143238628,
                "url": "https://finnhub.io/api/news?id=180ecaf137f2b0b499b3bc573bd860420cf5b1140d93b6e70a67a8c0167faeed",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "Revvity (RVTY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.",
                "category": "company",
                "datetime": 1793113802,
                "headline": "Will Revvity (RVTY) Beat Estimates Again in Its Next Earnings Report?"
              },
              {
                "id": 143237330,
                "url": "https://finnhub.io/api/news?id=a520b60ccbfe910f408fa3da6893d490c7a366bfadc368dabad35dac9c4b000f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "Revvity (RVTY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
                "category": "company",
                "datetime": 1793106018,
                "headline": "Revvity (RVTY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release"
              },
              {
                "id": 143135824,
                "url": "https://finnhub.io/api/news?id=7f9e224299f6aa2a2aa48460713116c41b65e322f07c48fe558cbb0e57f91232",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "ELV vs. RVTY: Which Stock Is the Better Value Option?",
                "category": "company",
                "datetime": 1792766403,
                "headline": "ELV vs. RVTY: Which Stock Is the Better Value Option?"
              },
              {
                "id": 142913436,
                "url": "https://finnhub.io/api/news?id=e01b57a1aa6db01da5aa5e2f48e508f0242d8475c162f68daecf96884fa9fb4f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "Revvity (RVTY) is back on investor calendars after announcing third quarter 2026 results are due on 3 November, with earnings per share expected to be higher and fresh conference appearances scheduled soon after. Revvity’s share price has surged over the past quarter, with a 30 day share price return of 18.4% and a 90 day gain of 36.2%. The 1 year total shareholder return of 65.6% contrasts with a weaker 5 year total shareholder return that is still down 12.8%, suggesting momentum has...",
                "category": "company",
                "datetime": 1792062930,
                "headline": "Revvity (RVTY), What Is Drawing Fresh Attention Now?"
              },
              {
                "id": 142894962,
                "url": "https://finnhub.io/api/news?id=7a9a967625dcafa691a84760f6f658adee5a58425c6fda07f464d246eeb10b18",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "Revvity has delivered a strong share price run over the past year, and the key issue now is whether that market enthusiasm lines up with the cash the business can realistically generate. With the stock recently closing at US$152.12, investors are asking if the current tag fairly reflects the company’s underlying cash flows or if expectations are stretching ahead of what the business can support. Over the past 12 months, Revvity has returned 65.6%, which puts real weight on the question of...",
                "category": "company",
                "datetime": 1792026927,
                "headline": "Revvity (RVTY) Stock Could Be 12% Stretched On Cash Flow"
              },
              {
                "id": 142592011,
                "url": "https://finnhub.io/api/news?id=1354c9a3ac86acca82d61b1988ec9d31e1f0743e2810cf95605e1c46072883de",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "Revvity (RVTY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).",
                "category": "company",
                "datetime": 1790953202,
                "headline": "Revvity (RVTY) Upgraded to Buy: What Does It Mean for the Stock?"
              },
              {
                "id": 142499577,
                "url": "https://finnhub.io/api/news?id=ff4832de7ba97e9983ed854de2a013c27c693bf0523e62c4715efc273d08445c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "Revvity has been on fire lately. In the past six months alone, the company’s stock price has rocketed 78%, reaching $150.93 per share. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.",
                "category": "company",
                "datetime": 1790700002,
                "headline": "Revvity (RVTY): Buy, Sell, or Hold Post Q2 Earnings?"
              }
            ],
            "raw_source": [
              {
                "id": 143238628,
                "url": "https://finnhub.io/api/news?id=180ecaf137f2b0b499b3bc573bd860420cf5b1140d93b6e70a67a8c0167faeed",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "Revvity (RVTY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.",
                "category": "company",
                "datetime": 1793113802,
                "headline": "Will Revvity (RVTY) Beat Estimates Again in Its Next Earnings Report?"
              },
              {
                "id": 143237330,
                "url": "https://finnhub.io/api/news?id=a520b60ccbfe910f408fa3da6893d490c7a366bfadc368dabad35dac9c4b000f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "Revvity (RVTY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
                "category": "company",
                "datetime": 1793106018,
                "headline": "Revvity (RVTY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release"
              },
              {
                "id": 143234895,
                "url": "https://finnhub.io/api/news?id=5491d74548f6cdd1a26faca6e225353d298cb39cd81221885d4784c83e851c43",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "HSIC gears up for Q3 earnings with revenue growth expected across its three segments, fueled by dental products, specialty demand and cloud-based technology.",
                "category": "company",
                "datetime": 1793103660,
                "headline": "Henry Schein to Report Q3 Earnings: Here's What You Should Know"
              },
              {
                "id": 143198458,
                "url": "https://finnhub.io/api/news?id=17d1de96afb4be76bff0c040e451945dca7eae0bf590db2132141c5ac2406852",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "CareDx's Q3 earnings are in focus as transplant testing growth, stronger reimbursement and oncology expansion drive revenue prospects despite potential margin pressures.",
                "category": "company",
                "datetime": 1793019480,
                "headline": "CareDx to Report Q3 Earnings: Transplant Testing Growth in Focus"
              },
              {
                "id": 143135824,
                "url": "https://finnhub.io/api/news?id=7f9e224299f6aa2a2aa48460713116c41b65e322f07c48fe558cbb0e57f91232",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "ELV vs. RVTY: Which Stock Is the Better Value Option?",
                "category": "company",
                "datetime": 1792766403,
                "headline": "ELV vs. RVTY: Which Stock Is the Better Value Option?"
              },
              {
                "id": 143133781,
                "url": "https://finnhub.io/api/news?id=04d51346696b34e124e6afcf725f494ecd3ddfa35bc03eef29bcd399ae56011d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "IDXX heads into Q3 earnings with expected revenue and EPS growth, fueled by CAG Diagnostics momentum, higher testing volumes and software gains.",
                "category": "company",
                "datetime": 1792754340,
                "headline": "Here's How IDEXX Laboratories Is Placed Ahead of Q3 Earnings"
              },
              {
                "id": 143102604,
                "url": "https://finnhub.io/api/news?id=a76f0ed353a1c120d797e571e941ea44b4c416e3059d34b06d12f5e99c709e26",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "RVTY's AI-first Signals LabGistics aims to streamline scientific workflows, enhance R&D-to-manufacturing coordination and expand software growth opportunities.",
                "category": "company",
                "datetime": 1792676040,
                "headline": "Revvity Launches Signals LabGistics to Coordinate Scientific Workflows"
              },
              {
                "id": 143100727,
                "url": "https://finnhub.io/api/news?id=289290f2e6c074da6aea40a8786bc0fa2e7d2cee862b3cda673273eddad5bcbd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "ALGN's Q3 earnings may benefit from Clear Aligner growth and digital innovations, while capital equipment market challenges could weigh on results.",
                "category": "company",
                "datetime": 1792670880,
                "headline": "Align Technology to Report Q3 Earnings: What's in the Cards?"
              },
              {
                "id": 143067925,
                "url": "https://finnhub.io/api/news?id=9cbddd52008e4e3539c48d0ca4b4049bdceb8efedb6c60a1ecc35f94f1221608",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "LH's Q3 earnings may benefit from strong diagnostics demand, specialty testing expansion and acquisitions, with revenues projected to grow 5.7%.",
                "category": "company",
                "datetime": 1792585680,
                "headline": "Labcorp Prepares to Report Q3 Earnings: What's in the Cards?"
              },
              {
                "id": 143024784,
                "url": "https://finnhub.io/api/news?id=4a9d26d35da1e5e461449695c45229413171abd8a9352e38ca0a21273083d4e0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "WALTHAM, Mass., October 20, 2026--Revvity, Inc. (NYSE: RVTY), announced that its Revvity Signals Software business is launching the Signals LabGistics™ solution, an AI-first, scientific workflow orchestration solution designed to connect and coordinate processes, workflows, and tasks from discovery to manufacturing.",
                "category": "company",
                "datetime": 1792497600,
                "headline": "Revvity Launches Signals LabGistics Solution to Connect and Orchestrate Scientific Workflows"
              },
              {
                "id": 142946022,
                "url": "https://finnhub.io/api/news?id=9537a091848dca510e358760b6fdd72cf27d86be3a48dbe7bc1c7d8f6f907d6c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.",
                "category": "company",
                "datetime": 1792157979,
                "headline": "1 Cash-Producing Stock to Own for Decades and 2 We Question"
              },
              {
                "id": 142913436,
                "url": "https://finnhub.io/api/news?id=e01b57a1aa6db01da5aa5e2f48e508f0242d8475c162f68daecf96884fa9fb4f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "Revvity (RVTY) is back on investor calendars after announcing third quarter 2026 results are due on 3 November, with earnings per share expected to be higher and fresh conference appearances scheduled soon after. Revvity’s share price has surged over the past quarter, with a 30 day share price return of 18.4% and a 90 day gain of 36.2%. The 1 year total shareholder return of 65.6% contrasts with a weaker 5 year total shareholder return that is still down 12.8%, suggesting momentum has...",
                "category": "company",
                "datetime": 1792062930,
                "headline": "Revvity (RVTY), What Is Drawing Fresh Attention Now?"
              },
              {
                "id": 142906390,
                "url": "https://finnhub.io/api/news?id=5c850fabd074fba949692037137bcd030e692025571a7d5b2b7ed467985abb0f",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1728138175/image_1728138175.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "RVTY",
                "summary": "While AI can design prospective drug molecules in seconds, validating whether they work still depends on slow physical wet-lab testing and custom testing tools.",
                "category": "company",
                "datetime": 1792040640,
                "headline": "How To Invest In AI Drug Discovery"
              },
              {
                "id": 142894962,
                "url": "https://finnhub.io/api/news?id=7a9a967625dcafa691a84760f6f658adee5a58425c6fda07f464d246eeb10b18",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "Revvity has delivered a strong share price run over the past year, and the key issue now is whether that market enthusiasm lines up with the cash the business can realistically generate. With the stock recently closing at US$152.12, investors are asking if the current tag fairly reflects the company’s underlying cash flows or if expectations are stretching ahead of what the business can support. Over the past 12 months, Revvity has returned 65.6%, which puts real weight on the question of...",
                "category": "company",
                "datetime": 1792026927,
                "headline": "Revvity (RVTY) Stock Could Be 12% Stretched On Cash Flow"
              },
              {
                "id": 142883187,
                "url": "https://finnhub.io/api/news?id=df66f5276cb53baa566420fe62459f6b065660547d648c42c6cc0bc813b10767",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "DGX heads into Q3 earnings with expected revenue and EPS growth, fueled by strong clinical demand, advanced diagnostics and operational efficiencies.",
                "category": "company",
                "datetime": 1791979920,
                "headline": "Here's How Quest Diagnostics Is Placed Ahead of Q3 Earnings"
              },
              {
                "id": 142876719,
                "url": "https://finnhub.io/api/news?id=815d434e0657f117bffe7d1062a8fa7c74232073479b3c1504d9540821cd79e2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, positive market sentiment, or significant industry tailwinds.",
                "category": "company",
                "datetime": 1791971687,
                "headline": "3 Hyped Up  Stocks We Think Twice About"
              },
              {
                "id": 142882355,
                "url": "https://finnhub.io/api/news?id=8042888ff6311b62097af82a31baa261ee19cca2862ead380bd66b34f5883b26",
                "image": "https://cdn.benzinga.com/files/images/story/2025/07/10/valuestock_2.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "RVTY",
                "summary": "Revvity (NYSE:RVTY) has outperformed the market over the past 15 years by 1.91% on an annualized basis producing an average annual return of 15.11%. Currently, Revvity has a market capitalization of $17.36 billion.",
                "category": "company",
                "datetime": 1791918936,
                "headline": "Here's How Much $100 Invested In Revvity 15 Years Ago Would Be Worth Today"
              },
              {
                "id": 142851273,
                "url": "https://finnhub.io/api/news?id=89e904f7ec9123e4dd8479b5415fe596d2d08807c1cc886a77c4cd973f5b9ea8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "TMO gears up for Q3 earnings, with revenue and EPS growth expected amid strong bioproduction demand, product innovations and clinical research strength.",
                "category": "company",
                "datetime": 1791897900,
                "headline": "Thermo Fisher to Report Q3 Earnings: What's in the Cards?"
              },
              {
                "id": 142847674,
                "url": "https://finnhub.io/api/news?id=adebb5b294eb51be2e2bab0fb74566b676300da5221aea95f426696e0c6a6a9a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "WALTHAM, Mass., October 13, 2026--Revvity, Inc. (NYSE: RVTY), today announced it will present at the following investor conferences:",
                "category": "company",
                "datetime": 1791892800,
                "headline": "Revvity to Present at Upcoming Investor Conferences"
              },
              {
                "id": 142882356,
                "url": "https://finnhub.io/api/news?id=7212c13d3a03394ce412a77bb8f3f604130da5b24939c5f480c076a97a5ba191",
                "image": "",
                "source": "Benzinga",
                "related": "RVTY",
                "summary": "TD Cowen  analyst Dan Brennan   maintains Revvity (NYSE:RVTY) with a Buy and raises the price target from $130 to $175.",
                "category": "company",
                "datetime": 1791892125,
                "headline": "TD Cowen Maintains Buy on Revvity, Raises Price Target to $175"
              },
              {
                "id": 142728921,
                "url": "https://finnhub.io/api/news?id=0dd7d1b383dd91d4ef55e272b4d0e25c1c563ddef68dfa481dcf459a3f0016fa",
                "image": "https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp",
                "source": "ChartMill",
                "related": "RVTY",
                "summary": "Looking for opportunities in today's market? Check out the S&P500 gap up and gap down stocks on Thursday and stay ahead of the market trends.",
                "category": "company",
                "datetime": 1791470101,
                "headline": "Which S&P500 stocks are gapping on Thursday?"
              },
              {
                "id": 142693767,
                "url": "https://finnhub.io/api/news?id=b58fc40ae5e598dea8cde16f52126f564cf1c2ee3879ed84982d201a4a9383d5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "281-Page Report Tracks Post-Pandemic Research Growth Across Pharma, Research and Industry/Cosmetic Users as 3D Assays, Automation and Immuno-oncology Reshape Drug DiscoveryDublin, Oct. 07, 2026 (GLOBE NEWSWIRE) -- \"Cell-Based Assay & High Content Screening Market 2025-2029 - Forecasts by User and Product, with Executive and Consultant Guides\" has been added to ResearchAndMarkets.com's offering. Research and Markets has published Cell-Based Assay & High Content Screening Market 2025-2029 - Foreca",
                "category": "company",
                "datetime": 1791373560,
                "headline": "Cell-Based Assay & High Content Screening Market Report Reveals Why Technology Is Outpacing the Market, Profiling Thermo Fisher, Roche, Sartorius, Revvity & 50 Other Key Players"
              },
              {
                "id": 142728288,
                "url": "https://finnhub.io/api/news?id=8d9b36bda25cc3dae2a96a864dce6dd65b5b0892657a362c9ee1d7be1a2a3179",
                "image": "",
                "source": "Benzinga",
                "related": "RVTY",
                "summary": "Barclays  analyst Luke Sergott   maintains Revvity (NYSE:RVTY) with a Equal-Weight and raises the price target from $115 to $160.",
                "category": "company",
                "datetime": 1791372093,
                "headline": "Barclays Maintains Equal-Weight on Revvity, Raises Price Target to $160"
              },
              {
                "id": 142697475,
                "url": "https://finnhub.io/api/news?id=5293fb6cb9cd661ac9f7d6788a377cca7b6432efc60ab2ab7a30c515d13e581b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "Revvity will release its third-quarter earnings next month, and analysts anticipate a high single-digit bottom-line growth.",
                "category": "company",
                "datetime": 1791363263,
                "headline": "Revvity Earnings Preview: What to Expect"
              },
              {
                "id": 142694619,
                "url": "https://finnhub.io/api/news?id=1ca703b7fad07089c730aef2b5ff799b55d0fa3971297d860aacc4957655612f",
                "image": "",
                "source": "Benzinga",
                "related": "RVTY",
                "summary": "William Blair  analyst Matt Larew   initiates coverage on Revvity (NYSE:RVTY) with a Outperform rating.",
                "category": "company",
                "datetime": 1791303270,
                "headline": "William Blair Initiates Coverage On Revvity with Outperform Rating"
              },
              {
                "id": 142694620,
                "url": "https://finnhub.io/api/news?id=947600016a722f37a30f498b8ac2a29d931f9e0e2fe0b9640f578c701ecc477d",
                "image": "https://cdn.benzinga.com/files/images/story/2026/10/06/Revvity-Inc.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "RVTY",
                "summary": "William Blair initiates Revvity (RVTY) at Outperform, citing AI tailwinds, life sciences recovery, and potential 20%+ stock upside.",
                "category": "company",
                "datetime": 1791298272,
                "headline": "Revvity Nears 52-Week High, but This Analyst Thinks Stock Can Climb Another 20%"
              },
              {
                "id": 142663473,
                "url": "https://finnhub.io/api/news?id=77771d918fee3d8e31646d64918184c9a6dda8db8f26fbdf378ad0829d4dcbf5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "WALTHAM, Mass., October 06, 2026--Revvity, Inc. (NYSE: RVTY), today announced it will host its 2026 Investor Day on Friday, November 13 at 9:00 a.m. ET.",
                "category": "company",
                "datetime": 1791288000,
                "headline": "Revvity to Host Investor Day"
              },
              {
                "id": 142592011,
                "url": "https://finnhub.io/api/news?id=1354c9a3ac86acca82d61b1988ec9d31e1f0743e2810cf95605e1c46072883de",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "Revvity (RVTY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).",
                "category": "company",
                "datetime": 1790953202,
                "headline": "Revvity (RVTY) Upgraded to Buy: What Does It Mean for the Stock?"
              },
              {
                "id": 142588838,
                "url": "https://finnhub.io/api/news?id=20f528af1e1b120c026025dfda2cdf1c613fc223627e530195c33ed1dffc0e4d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "WALTHAM, Mass., October 02, 2026--Revvity, Inc. (NYSE: RVTY), today announced that it will release its third quarter 2026 financial results prior to market open on Tuesday, November 3, 2026. The Company will host a conference call the same day at 7:30 a.m. ET to discuss these results. Prahlad Singh, president and chief executive officer, and Max Krakowiak, chief financial officer, will host the conference call.",
                "category": "company",
                "datetime": 1790942400,
                "headline": "Revvity to Hold Earnings Call on November 3, 2026"
              },
              {
                "id": 142521568,
                "url": "https://finnhub.io/api/news?id=8796fb4f75396d1828b23a3b1b8c40d67fff4a675fd7b4ca8feac4460090c598",
                "image": "https://www.chartmill.com/images/uploads/CM_Unusual_Volume_Small_free_b9d2e60841.webp",
                "source": "ChartMill",
                "related": "RVTY",
                "summary": "Let's take a closer look at the S&P500 stocks with an unusual volume in today's session on Wednesday. Stay informed about the market activity below.",
                "category": "company",
                "datetime": 1790787900,
                "headline": "Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session."
              },
              {
                "id": 142499577,
                "url": "https://finnhub.io/api/news?id=ff4832de7ba97e9983ed854de2a013c27c693bf0523e62c4715efc273d08445c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "Revvity has been on fire lately. In the past six months alone, the company’s stock price has rocketed 78%, reaching $150.93 per share. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.",
                "category": "company",
                "datetime": 1790700002,
                "headline": "Revvity (RVTY): Buy, Sell, or Hold Post Q2 Earnings?"
              },
              {
                "id": 142498306,
                "url": "https://finnhub.io/api/news?id=b99b47066bf1db0d53f43dfd46ad34ae8002db612643d2fa307c56c3e05fdaf9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "RVTY's diagnostics growth, AI-driven demand and life sciences expansion support its outlook, though China and margin pressures pose near-term challenges.",
                "category": "company",
                "datetime": 1790687520,
                "headline": "Here's Why You Should Retain Revvity Stock in Your Portfolio for Now"
              },
              {
                "id": 142463267,
                "url": "https://finnhub.io/api/news?id=fc9a13a952922c8e6a07e852b9dc7e22771cf21ad57968453bc3b6669662339b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.",
                "category": "company",
                "datetime": 1790586156,
                "headline": "1 Unpopular Stock That Deserves Some Love and 2 Facing Headwinds"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 7,
            "negative_hits": 0,
            "positive_hits": 4,
            "recomputed_at_score": true,
            "sentiment_score_raw": 1.4,
            "source_article_count": 33,
            "discarded_article_count": 26
          },
          "sentimentPoints": 6
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 20.9,
        "grade": "一般",
        "items": {
          "bbPoints": 3,
          "adxPoints": 3,
          "sarPoints": 2.4000000000000004,
          "vcpPoints": 3,
          "macdPoints": 2.4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 3,
            "vcp_reason": "波幅收縮(23.2%→7.9%)；量縮(v10/v30=0.76)；跌縮量(近10日3日)；站上MA50；Ready=Y；Confirm=N",
            "vcp_metrics": {
              "up_days": 6,
              "vol_ref": 2070756.6666666667,
              "down_days": 3,
              "vcp_ready": true,
              "above_ma50": true,
              "avg_vol_10": 1575570,
              "avg_vol_20": 1789540,
              "avg_vol_30": 2070756.6666666667,
              "range_pct_10": 0.07932781416038535,
              "range_pct_20": 0.12078339305572723,
              "range_pct_30": 0.23217595452860504,
              "up_expand_ok": false,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": true,
              "down_shrink_ok": true,
              "up_expand_days": 1,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 0.7608668007024807,
              "dist_to_20d_high": 0.0264060150375939,
              "down_shrink_days": 3,
              "breakout_level_20d": 166.25,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.3416711016498129
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": true
          },
          "kdjAdxPoints": 0.7,
          "rsiKdjPoints": 3.2,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 0.4,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0,
          "volumePointsTechnical": 0.8
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "一般",
        "items": {
          "position": {
            "score": 1.3,
            "details": {
              "atrPct": 3.441245520820462,
              "turnoverUsdM": 251.14602250000004,
              "liquidityPoints": 0.6,
              "volatilityPoints": 0.7
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.RVTY",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 150.72,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 1,
              "rsi_score": 3,
              "macd_score": 1.5,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1,
            "stop_loss_percent": 6.9,
            "take_profit_price": 173.3249,
            "target_multiplier": 1.9,
            "technical_strength": 1.63,
            "take_profit_percent": 7.1
          },
          "positionPoints": 1.3,
          "stopLossPoints": 1.8,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 6.882491041640924,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 92.86,
    "atr": {
      "atr": 5.57,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 4,
      "atr_pct": 3.44
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "超買或超賣風險",
      "score": 2,
      "value": 173.71
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "派發",
      "score": 2,
      "value": -0.1042
    },
    "kdj": {
      "d": 69.18,
      "j": 104.37,
      "k": 80.91,
      "rule": "Cursor_18.24 K/D cross",
      "score": 4,
      "signal": "金叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "弱流入",
      "score": 4,
      "value": 47.65
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 10,
      "trend": "強流入",
      "value": 18055225,
      "recentSlope": 870492.5,
      "previousSlope": -266960
    },
    "rsi": 66.1,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 8,
      "trend": "上升",
      "value": 149.0868,
      "position": "SAR喺價下",
      "distancePct": 7.89,
      "previousTrend": "上升"
    },
    "ma50": 141.8674,
    "macd": {
      "macd": 4.8142967611370295,
      "trend": "中性偏多",
      "signal": 4.952492662276299,
      "histogram": -0.1381959011392695
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 10,
      "value": 154.7341,
      "position": "連續5日>VWAP",
      "consecutiveAbove": 6
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "無力",
      "ratio": 0.87,
      "score": 4,
      "avgVolume": 1787116,
      "currentVolume": 1551625
    },
    "derived": {
      "ma20": 154.809,
      "ma50": 141.8674,
      "prevClose": 160.39,
      "avgVolume10": 1591973,
      "avgVolume20": 1787116,
      "changePercent": 0.92,
      "avgVolumeForScore": 1787116
    },
    "ma_cross": {
      "ma20": 154.809,
      "ma50": 141.8674,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 154.3545,
      "prevMa50": 140.9536,
      "spreadPct": 9.12,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 148.4762,
      "upper": 161.1418,
      "position": "上半部"
    },
    "rsi_short": 100,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.87
    }
  }
}

{
  "close": 161.86,
  "volume": 1551625,
  "changePercent": 0.92
}